Your search history is turned on.
Date: November 23, 2023 Jurisdictions: All jurisdictions
Microsoft Word - Khiron - MCR re Closing (November 2023)(58534198.4) (004).doc FORM 51-102F3 MATERIAL CHANGE REPORT Item 1 Name and Address of Company Khiron Life Sciences Corp. (the Company) 2300 500 Burrard Street Vancouver, BC V6C 2B5 Item 2 Date of Material Change November 17, 2023 Item 3 News Release A news release disclosing the material change ...
Date: November 17, 2023 Jurisdictions: All jurisdictions
Microsoft Word - Khiron - PR_Nov172023 re Closing.docx KHIRON LIFE SCIENCES ANNOUNCES CLOSING OF THE SALE OF ITS EUROPEAN BUSINESS Toronto, Canada November 17, 2023 Khiron Life Sciences Corp. (Khiron or the Company) (TSXV: KHRN, OTCQX: KHRNF) is pleased to announce that the Company has completed the sale of its European subsidiaries, being Khiron Europe Gmb...
Date: November 16, 2023 Jurisdictions: All jurisdictions
AMENDED AND RESTATED SHARE PURCHASE AGREEMENT BETWEEN KHIRON LIFE SCIENCES CORP. AND 2518542 ALBERTA LTD. DATED AS OF NOVEMBER 15, 2023 TABLE OF CONTENTS Article 1 Interpretation ..................................................................................................................1 1.1 Definitions ............
Microsoft Word - Khiron - PR_Nov162023 re Amended and Restated SPA.docx KHIRON LIFE SCIENCES ANNOUNCES UPDATE TO THE PROPOSED SALE OF ITS EUROPEAN BUSINESS Toronto, Canada November 16, 2023 Khiron Life Sciences Corp. (Khiron or the Company) (TSXV: KHRN, OTCQX: KHRNF) today announced that the Company and 2518542 Alberta Ltd., a company controlled by Avonlea...
Date: August 7, 2023 Jurisdictions: All jurisdictions
Microsoft Word - Khiron - MCR (August 6 2023)(57864535.5).doc FORM 51-102F3 MATERIAL CHANGE REPORT Item 1 Name and Address of Company Khiron Life Sciences Corp. (Khiron or the Company) 2300 500 Burrard Street Vancouver, BC V6C 2B5 Item 2 Date of Material Change July 28, 2023 Item 3 News Release A news release disclosing the material change was disse...
Date: July 28, 2023 Jurisdictions: All jurisdictions
SHARE PURCHASE AGREEMENT BETWEEN KHIRON LIFE SCIENCES CORP. AND 2518542 ALBERTA LTD. DATED AS OF JULY 28, 2023 TABLE OF CONTENTS Article 1 Interpretation ................................................................................................................. 1 1.1 Definitions ...............
Microsoft Word - KHRN - PR_July282023_Definitive Agreement.docx KHIRON LIFE SCIENCES ENTERS DEFINITIVE AGREEMENT FOR THE SALE OF ITS EUROPEAN BUSINESS Toronto, Canada July 28, 2023 Khiron Life Sciences Corp. (Khiron or the Company) (TSXV: KHRN, OTCQX: KHRNF) announced today that further to its news release dated June 5, 2023, the Company has entered into a...
Date: February 16, 2023 Jurisdictions: All jurisdictions
Khiron Closes Additional Loan with Investment-Grade Bank The term loan, provided by one of Colombia's largest and traditional private banks, provides immediate access to liquidity, and further strengthens Khiron's credibility with long-established banking institutions. Toronto, Ontario--(Newsfile Corp. - February 16, 2023) - Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (WKN: A2JMZC...
Date: February 14, 2023 Jurisdictions: All jurisdictions
Khiron Closes Revolving Credit Facility with Financing Company in Colombia Toronto, Ontario--(Newsfile Corp. - February 14, 2023) - Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF) (FSE: A2JMZC) ("Khiron" or the "Company"), announces that its wholly owned subsidiary ZereniaTM Colombia has closed an unsecured revolving credit facility of CAD 580,0001 with a private financing company in Colomb...
Date: January 19, 2023 Jurisdictions: All jurisdictions
Khiron begins dispensation of insurance-covered prescriptions in Colombia Following the Government of Colombias decision on insurance coverage for medical cannabis, Khiron has begun dispensing medical cannabis to its patient base under the new mandate. TORONTO, January 19, 2023 /CNW/ - Khiron Life Sciences Corp. ("Khiro...